Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

LHX

L3Harris Technologies Reports 3% Revenue Growth

L3Harris Technologies (NYSE: LHX) has reported its full year and fourth quarter 2025 results, highlighting a book-to-bill ratio of 1.3x and a 3% increase in revenue to $21.9 billion for the full year, with a 5% organic growth. The company's cash from operations surged by 21% to $3.1 billion, while adjusted free cash flow also rose by 21% to $2.8 billion.

In the fourth quarter, L3Harris Technologies saw a 2% increase in revenue to $5.6 billion, with a 6% organic growth. The company's operating margin for the full year was 9.7%, with an adjusted segment operating margin of 15.8%. Diluted EPS for the year increased by 8% to $8.53, while non-GAAP diluted EPS surged by 11% to $10.73.

L3Harris Technologies reported a strong performance across its segments. The Communication Systems segment experienced a 3% increase in revenue, reaching $5.7 billion for the full year, with an operating margin of 25.2%. The Integrated Mission Systems segment saw flat revenue, but excluding the impact of the divestiture of its CAS business, organic revenue increased by 8%. The Space & Airborne Systems segment achieved a 1% increase in revenue, reaching $6.9 billion for the full year, with an operating margin of 12.3%. The Aerojet Rocketdyne segment reported a 10% increase in revenue to $2.8 billion for the full year, with an adjusted segment operating margin of 12.5%.

Looking ahead to 2026, L3Harris Technologies has provided guidance, expecting revenues to range from $23 billion to $23.5 billion. The company also anticipates a diluted EPS in the range of $11.30 to $11.50 and a free cash flow of approximately $3.0 billion.

The market has reacted to these announcements by moving the company's shares 1.77% to a price of $346.46. Check out the company's full 8-K submission here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS